Avanos Medical Q3 2024 Adj. EPS $0.36 Beats $0.35 Estimate, Sales $170.400M Miss $175.333M Estimate
Portfolio Pulse from Benzinga Newsdesk
Avanos Medical reported Q3 2024 earnings per share of $0.36, slightly beating the estimate of $0.35. However, sales were $170.4 million, missing the expected $175.333 million and showing a slight decrease from last year's $171.3 million.
October 30, 2024 | 10:47 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Avanos Medical's Q3 2024 earnings per share slightly exceeded expectations, but sales fell short and decreased compared to the previous year.
The earnings per share beat expectations, which is positive, but the sales miss and year-over-year decline could offset this positive impact, leading to a neutral short-term price direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100